Speaker illustration

Doctor Patricia Sansilvestri-Morel

Servier Research Institute, Suresnes (France)

phD in Hematology/ Cellular and Molecular Biology (France) Project Director in Cardiovascular & Metabolic Diseases Research Servier Research Institute

S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism

Event: ESC Congress 2020

Topic: Anticoagulants

Session: Antithrombotic Therapy Update


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb